Addex Therapeutics Ltd (ADXN)
8.78
-0.22
(-2.44%)
USD |
NASDAQ |
May 09, 12:36
Addex Therapeutics Net Income (TTM): -11.76M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.76M |
| September 30, 2023 | -12.33M |
| June 30, 2023 | -13.62M |
| March 31, 2023 | -18.13M |
| December 31, 2022 | -21.84M |
| September 30, 2022 | -22.84M |
| June 30, 2022 | -22.51M |
| March 31, 2022 | -20.17M |
| December 31, 2021 | -16.79M |
| Date | Value |
|---|---|
| September 30, 2021 | -14.34M |
| June 30, 2021 | -14.02M |
| March 31, 2021 | -12.10M |
| December 31, 2020 | -13.64M |
| September 30, 2020 | -14.98M |
| June 30, 2020 | -15.01M |
| March 31, 2020 | -16.27M |
| December 31, 2019 | -14.87M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-22.84M
Minimum
Sep 2022
-11.76M
Maximum
Dec 2023
-16.19M
Average
-14.98M
Median
Sep 2020
Net Income (TTM) Benchmarks
| AC Immune SA | -60.14M |
| CRISPR Therapeutics AG | -153.61M |
| NLS Pharmaceutics Ltd | -15.47M |
| Molecular Partners AG | -69.02M |
| MoonLake Immunotherapeutics | -36.01M |